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Abstract A novel lectin, called VisalbCBA, was isolated from 
European mistletoe (Viscum album). This lectin differs com- 
pletely from the classical galactose/N-acetylgalactosamine-bind- 
ing mistletoe lectins MLI, MLII and MLIII. Biochemical 
analyses indicated that VisalbCBA is a dimeric protein composed 
of two identical subunits of approx. 10 kDa. VisalbCBA exhibits 
specificity towards oligomers of N-acetylglucosamine and shows 
sequence homology to the previously isolated chitin-binding plant 
proteins. Although VisalbCBA is less toxic than the other 
mistletoe lectins, it definitely exhibits cytotoxic properties. The 
possible involvement of VisalbCBA in the biological and 
therapeutic effects of mistletoe is discussed. 
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mistletoe lectins exhibit quite different biological activities. 
Most likely, the therapeutic effects of mistletoe preparations 
are based on the immunomodulatory activity of MLI  [1,2,8]. 
In this report we present evidence that mistletoe contains 
besides the three above-mentioned type 2 RIP/lectins also a 
small agglutinin, which on the basis of its structure and spe- 
cificity can be classified in the group of chitin-binding plant 
lectins composed of hevein domains [9]. The discovery of the 
novel agglutinin ot only demonstrates that mistletoe contains 
two groups of totally different lectins, but also raises the ques- 
tion of whether this new lectin possibly contributes either 
positively or negatively to the therapeutic effects of mistletoe 
preparations. Since a similar chitin-binding lectin from the 
rhizomes of stinging nettle (Urtica dioica) is a potent super- 
antigen in mice [10], the latter question is certainly relevant. 
I. Introduction 
European mistletoe (Viscum album) has become an impor- 
tant issue in lectinology because there are indications that the 
therapeutic applications of this medicinal plant are linked to 
the biological activities of its lectins. Detailed studies have 
demonstrated that leaves and other tissues of this half parasite 
contain three different lectins [1,2]. Although these lectins dif- 
fer from each other with respect o their molecular structure 
and carbohydrate-binding specificity, they all clearly belong to 
the so-called type 2 ribosome-inactivating proteins (RIP) [3]. 
Type 2 RIP are bifunctional proteins composed of two differ- 
ent disulphide-bridge-linked polypeptide chains. The RNA N- 
glycosidase activity resides in the so-called A chain whereas 
the sugar-binding activity is associated with the B chain. Both 
chains are derived from a single precursor by the post-transla- 
tional excision of a linker sequence between the (N-terminal) 
A-domain and the (C-terminal) B-domain and are held to- 
gether by a disulphide bridge. Mistletoe lectin I (MLI) is a 
dimer of two [A-s-s-B] pairs and exhibits a preferential speci- 
ficity towards galactose [4-7]. In contrast, lectin II (MLII) and 
lectin III (MLII I)  are monomeric type 2 RIP exhibiting spe- 
cificity towards galactose/N-acetylgalactosamine and N-acetyl- 
galactosamine, respectively [1,2]. As could be expected from 
the differences in carbohydrate-binding specificity the three 
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2. Materials and methods 
2.1. Materials 
All experiments were carried out with materials from a single mis- 
tletoe (V. album L.) plant grown on a local poplar (Populus hybr.) 
tree. The plant was collected at the end of September and processed 
immediately. 
A mixture of N-acetylglucosamine oligomers was prepared from 
crude crab shell chitin (type C-7170 from Sigma) as described by 
Kilpatrick and Yeoman [11]. 
2.2. Isolation of the chit&-binding mistletoe lectin 
1 kg of leaves and young branches of mistletoe were homogenized 
in I0 1 of 20 mM acetic acid with a Waring blender. The homogenate 
was filtered through cheese cloth, centrifuged (8000xg for 10 min) 
and the resulting supernatant decanted and filtered through glass wool 
(to remove the floating particles). After the addition of 1.5 g/1 CaC12, 
the extract was brought o pH 9.0 (with 1 N NaOH) and kept in the 
cold (2°C) for about 3 h. The precipitate was removed by centrifuga- 
tion (3000xg for 10 min) and the cleared extract adjusted to pH 3.0 
(with 1 N acetic acid). After standing overnight in the cold room, the 
extract was recentrifuged (3000xg for 10 min) and the supernatant 
filtered through filter paper (Whatman 3MM). The filtrate was diluted 
with an equal volume of distilled water and applied onto a cation 
exchanger column (10 cmx5 cm; 200 ml bed volume) of S Fast 
Flow (Pharmacia, Uppsala, Sweden) equilibrated with 20 mM acetic 
acid. After loading the proteins, the column was washed with 2 1 of 20 
mM Na-formate (pH 3.8) and the bound proteins eluted with 500 ml 
of 0.5 M NaC1 in the same buffer. 
To remove the type 2 RIP MLI, MLII and MLIII, the protein 
mixture desorbed from the S Fast Flow column was subjected to 
consecutive affinity chromatography on galactose-Sepharose 4B and 
fetuin-Sepharose 4B. Therefore, the partially purified protein fraction 
was adjusted to pH 7.4 (with 1 N NaOH) and loaded onto a column 
(10 cm x 2.6 cm; about 50 ml bed volume) of galactose-Sepharose 4B 
on which MLI is retained. After passing the protein solution, the 
column was washed with 200 ml of PBS. The MLI-depleted protein 
fraction and the washing solution were combined and applied onto a 
column (10 cm x 2.6 cm; about 50 ml bed volume) of fetuin-Sepharose 
4B to remove MLII and MLIII. After loading the MLl-depleted frac- 
tion, the column was washed with 200 ml of PBS. The unbound 
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proteins (which were free of MLI, MLII and MLIII) were combined 
with the first 200 ml of PBS of the washing solution and applied onto 
a column (20 cm ×2.6 cm; about 100 ml bed volume) of chitin (type 
C-7170 from Sigma). Unbound proteins were removed by washing the 
column with phosphate-buffered saline (PBS) until the A2sl) fell below 
0.01. Finally, the lectin was desorbed with 20 mM acetic acid, dialyzed 
against PBS and stored at -20°C until use. Alternatively, the lectin 
was dialyzed against water and lyophilized. 
2.3. Gel fihration 
Analytical gel filtration of the purified lectin was performed on a 
Pharmacia Superose 12 column using PBS containing 10 mg/ml of a 
mixture of N-acetylglucosamine oligomers (to avoid binding of the 
lectin to the column) as running buffer. Since the chitin-binding lectins 
composed of hevein domains behave somewhat anomalously upon gel 
filtration, the molecular mass of the novel mistletoe lectin was esti- 
mated using wheat germ agglutinin (34 kDa) and nettle lectin (8.5 
kDa) as marker proteins. 
2.4. Analytical methods 
Total neutral sugar was determined by the phenol/H2SO~ method 
[12], with D-glucose as standard. 
Lectin preparations were analyzed by sodium dodecyl sulphate- 
polyacrylamide gel electrophoresis (SDS-PAGE) using 12.5 25% 
(w/v) acrylamide gradient gels as described by Laemmli [13]. 
2.5. Agglutination assays 
Agglutination assays were carried out in small glass tubes in a final 
volume of 0.1 ml containing 90 /al of a 1% suspension of red blood 
cells and 10 gl of crude extracts or lectin solutions (each serially 
diluted with 2-fold increments). Agglutination was controlled visually 
after 1 h at room temperature. 
The carbohydrate-binding specificity of the lectin was determined 
using hapten inhibition assays with some glycoproteins (thyroglobu- 
lin, fetuin, asialofetuin and ovomucoid) and a series of simple sugars 
(cf. Table 1). 
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Fig. 1. SDS-PAGE of purified VisalbCBA. Samples (25 gg each) of 
unreduced and reduced VisalbCBA were run in lanes 1 and 2, re- 
spectively. Molecular mass reference proteins (lane R) were lyso- 
zyme (14 kDa), soybean trypsin inhibitor (20 kDa), carbonic anhy- 
drase (30 kDa), ovalbumin (43 kDa), bovine serum albumin (67 
kDa) and phosphorylase b (94 kDa). 
2.6. Amino acid sequence analysis 
The N-terminal amino acid sequence of the mistletoe lectin was 
determined by automated Edman degradation using a gas-phase se- 
quenator (Beckman LF 3600 TC) coupled to a high-performance liq-
uid chromatograph (Beckman Gold) for PTH amino acid identifica- 
tion. 
2.Z Mass spectrometry 
Mass spectrometry (MS) was performed using a MALDI-TOF (ma- 
trix-assisted laser desorption ionization time of flight) instrument; a 
VG TofSpec by Micromass Ltd. (Manchester, UK). Calibration was 
performed externally using horse heart cytochrome c singly and dou- 
bly charged ions ([M+H] + 12361.10 and [M+2H] 2+ 6181.05, respec- 
tively). The matrix employed was c~-cyano-4-hydroxycinnamic ac d 
(Aldrich). The instrument was operated in the linear mode with an 
accelerating voltage of 24000 V. The energy of the pulsed UV laser 
was adjusted to near threshold values for desorption/ionization n 
order to obtain optimal resolution at the observed masses. Approx. 
30 shots were averaged to obtain a spectrum. 
2.8. Cytotoxicity assays 
The cytotoxicity of VisalbCBA was determined on Molt4 cells (a 
cell line derived from human T cell leukemia) kindly provided by 
Prof. A.G. Tonevitsky (Institute of Immunology, Moscow). Cells 
were cultured as described by Ribereau-Gayon et al. [14]. For the 
cytotoxicity assays, cells were growth-arrested for 48 h in serum-free 
medium, plated in 96-well microtiter plates in culture medium con- 
taining increasing concentrations of lectins and incubated for 72 h. 
Cell viability was determined by the cytotoxicity assay of Mossman 
[15]. To each well 100 gl of nitroblue tetrazolium chloride was added. 
After incubation for 4 h the supernatant was removed and 200 gl 
solubilizer (20% SDS (w/v) dissolved in dimethylformamide/water 
1 : 1 (v/v)) added before reading the absorption at 580 nm in a micro- 
titer plate reader. 
3. Results 
3.1. Nomenclature o f  the mistletoe lectins/RIP 
According to the currently used nomenclature, the type 2 
RIP/lectins from mistletoe are referred to by the abbreviations 
MLI, MLII  and MLIII .  Since these abbreviations are trivial 
and, in addition, there is a possibility that mistletoe also con- 
tains other as yet unidentified type 2 RIP or related proteins, 
the novel lectin is not called MLIV. To distinguish the new 
chitin-binding agglutinin from the previously described galac- 
tose/N-acetylgalactosamine-binding type 2 RIP, it will be re- 
ferred to as V. album chitin-binding agglutinin or VisalbCBA. 
3.2. Isolation and characterization o f  the V. album 
chitin-b&ding agglutin& ( VisalbCBA )
VisalbCBA was isolated by a combination of classical pro- 
tein purification techniques and affinity chromatography. 
After partial purification by ion-exchange chromatography 
on a S Fast Flow column, the type 2 RIP MLI, MLI I  and 
MLII I  were removed from the total lectin fraction by two 
consecutive affinity chromatography steps on immobilized ga- 
lactose and fetuin, respectively. The final purification of Vi- 
salbCBA was achieved by affinity chromatography on a chitin 
column. Using the procedure described above the total yield 
was about 10 mg affinity purified VisalbCBA per kg of start- 
ing material. Since VisalbCBA is very well retained on the S 
Fast Flow column, and all the agglutinating activity of the 
MLI, MLII  and MLIII-free fraction was quantitatively re- 
tained on the chitin column, we presume that the overall 
recovery is reasonably high. Accordingly, the total content 
of VisalbCBA in the mistletoe leaves and stems is rather low. 
To determine the molecular structure of VisalbCBA, the 
affinity-purified lectin was analyzed by SDS-PAGE, mass 
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Fig. 2. Gel filtration of native VisalbCBA on a Superose 12 column. 
(A) Elution of a mixture of the chitin-binding lectins wheat germ 
agglutinin (34 kDa) (W) and Urtica dioica (stinging nettle) aggluti- 
nin (8 kDa) (U). (B) Elution pattern of VisalbCBA. 
spectrometry and gel filtration. Reduced (with 2-mercap- 
toethanol) VisalbCBA yielded a single polypeptide band of 
about 9 kDa upon SDS-PAGE whereas the unreduced protein 
migrated as a diffuse band with an apparent molecular mass 
of about 18 kDa (Fig. 1). Mass spectrometry ielded a mo- 
lecular ion [M+H] + at 10847 mass units and a doubly charged 
species [ML+2H] 2+ at 5425 mass units (results not shown). 
Native VisalbCBA eluted as a single symmetrical peak with an 
apparent molecular mass of about 18 kDa upon gel filtration 
chromatography on a Superose 12 column using the chitin- 
binding lectins from wheat germ and stinging nettle rhizomes 
as standards (Fig. 2). On the basis of the gel filtration, MS 
and SDS-PAGE data, it is concluded that VisalbCBA is a 
dimer of two identical subunits of 10.8 kDa. 
No carbohydrate could be detected in purified VisalbCBA 
Table 1 
Carbohydrate-binding specificity of VisalbCBA 
Sugar ~ ICs0 (gM) b Relative inhibitory potency 
GIcNAc 37 500 1 
GIcNAc dimer 2 000 19 
GlcNAc trimer 125 300 
GlcNAc tetramer 15 2 400 
~Sugars and glycoproteins which were not inhibitory at concentrations 
below 200 mM and 2 mg/ml, respectively, are not listed. They were: 
saccharose, glucose, 6-deoxyglucose, glucosamine, GIcNAc, cello- 
biose, glycogen, amylose, glucuronic acid, methyl-cc-D-mannopyrano- 
side, methyl-ot-D-glycopyranoside, maltose, trehalose, fructose, 2- 
deoxyglucose, methyl-C~-D-galactopyranoside, gal, GalNAc, melibiose 
raffinose, gentobiose, galacturonic acid, arabinose, L-fucose, D-fucose, 
xylose, rhamnose, sorbose, ribose, deoxyribose, NAN, erythreitol, 
arabitol, xylitol, sorbitol, laminarin, mucin, asialomucin ovomucoid, 
fetuin, asiolofetuin, mucin, asialomucin, and thyroglobulin. 
bICs0: concentration required to give a 50% inhibition of the agglu- 
tination of trypsin-treated rabbit erythrocytes ata lectin concentration 
of 20 gg/ml. 
by the phenol-sulphuric acid method indicating that the lectin 
is not glycosylated. 
VisalbCBA is readily soluble in water (up to 5 mg/ml) and 
in 20 mM acetic acid (up to 20 mg/ml). A solution of 1 mg/ml 
gives an A280 of 1.83. 
VisalbCBA was challenged with antibodies against MLI, 
MLI I  and MLII I .  Since neither polyclonal (goat and human) 
nor monoclonal antibodies reacted with VisalbCBA (results 
not shown), it is evident hat the chitin-binding lectin is sero- 
logically unrelated to the formerly described mistletoe type 2 
RIP/lectins. 
3.3. Agglutination properties and carbohydrate-binding 
specificity of VisalbCBA 
The specific agglutination activity (defined as the lowest 
lectin concentration which still yields a visible agglutination) 
was determined with untreated and trypsin-treated rabbit and 
human type A erythrocytes. VisalbCBA agglutinated un- 
treated and trypsin-treated rabbit red blood cells at concen- 
trations as low as 2.5 ml and 10 ~g/ml, respectively. When 
human erythrocytes were used, the values were 2 3-times 
higher (5 and 30 gg/ml, respectively). 
The carbohydrate-binding specificity of VisalbCBA was de- 
termined in some detail by hapten inhibition assays of the 
agglutination of rabbit erythrocytes. As shown in Table 1, 
only glcNAc and glcNAc oligomers were inhibitory. Since 
the dimers, trimers and tetramers of glcNAc were 19-, 300- 
and 2400-times, respectively, more potent inhibitors than the 
monomer, it is evident that the carbohydrate-binding site of 
VisalbCBA is most complementary to the trimer and tetramer 
of GlcNAc. It is also noteworthy that none of the glycopro- 
teins tested (ovomucoid, fetuin, asialofetuin, thyroglobulin, 
mucin and asialomucin) had any inhibitory effect at concen- 
trations below 2 mg/ml. 
3.4. Stability of VisalbCBA 
Most of the chitin-binding lectins composed of hevein do- 
mains are very stable proteins. To assess the stability of Vi- 
salbCBA, the effects of adverse conditions and some proteo- 
lytic enzymes were investigated in some detail. Commonly 
used proteases uch as trypsin and chymotrypsin did not af- 
fect the activity of the lectin. VisalbCBA was fully stable in 
the pH range between 1 and 12. In addition, VisalbCBA is 
IDH RCGRE ATPPG KLCND GRCCS QWG: V isa lbCBA 
E QCGRQ A GG KLCPN NLCCS QWG: heve in  
Q RCGSQ G GG GTCPA LWCCS IWG: net t le  lec t in  Domain  1 
E QCGRQ A GG ALCPG GNCCS QFG: bean ch i t inase  
**  * * ***  . * 
Fig. 3. Comparison of the N-terminal amino acid sequences of Vi- 
satbCBA and some chitin-binding plant proteins composed of he- 
vein domains. Cysteine residues (indicated in italics) were not identi- 
fied positively in the sequencer due to the instability of the 
underivatized PTH-cys (undetectable in the HPLC chromatogram). 
However, dehydro-alanine, a typical [~-elimination product of cy- 
steine was detected in all relevant cycles. The sequence data for he- 
vein, nettle lectin and bean chitinase were taken from Broekaert et 
al. [23], Beintema nd Peumans [24] and Broglie et al. [25], respec- 
tively. On the bottom line asterisks indicate identical amino acids at 
that position of the sequence whereas dots represent similar amino 
acids. 
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Table 2 
Comparison of the cytotoxicity of the different mistletoe lectins 
V~J. Peumans et al./FEBS Letters 396 (1996) 261~65 
Lectin Concentration ( g/ml) 
0 10 50 100 500 
VisalbCBA 100 + 0.2 101 _+ 1.1 91.1 + 2.6 82.5 + 1.4 38.4 _+ 3.8 
MLI 100+0.2 4_+ 1.8 0.5_+ 1.3 0 0 
MLII 100 _+ 0.2 10 + 2.7 0.2 _+ 0.9 0 0 
MLIII 100 _+ 0.2 24 _+ 1.8 0.8 + 1.2 0 0 
Cell viability is expressed as % of the control (without lectin). Experiments were performed in triplicate. 
also fairly heat-resistant. Over 50% of the agglutination activ- 
ity was retained after boiling the lectin solution in PBS for 5 
min. 
3.5. Amino acid sequencing of  VisalbCBA 
N-terminal amino acid sequencing of affinity-purified Vi- 
salbCBA yielded a single sequence. A comparison of the N- 
terminus of VisalbCBA to those of some other chitin-binding 
plant proteins and lectins revealed a striking homology (Fig. 
3). Although a few gaps have to be created to align the se- 
quences of VisalbCBA and the N-termini of hevein, nettle 
lectin and bean chitinase, the conserved positions of especially 
the cysteine residues trongly suggest hat VisalbCBA belongs 
to the family of chitin-binding plant lectins composed of he- 
vein domains. 
3.6. Cytotoxicity of  VisalbCBA 
The possible cytotoxic properties of VisalbCBA were as- 
sayed using Molt4 cells. As shown in Table 2, VisalbCBA 
definitely has a toxic effect on these cells at concentrations 
above 100 ng/ml. It is evident, however, that the toxicity of 
VisalbCBA is much lower than that of MLI,  MLI I  and 
MLII I .  
4. Discussion 
The present paper describes the isolation and partial char- 
acterization of a novel lectin from mistletoe, which based on 
its molecular structure, biochemical properties and sugar-spe- 
cificity studies belongs to the superfamily of chitin-binding 
plant proteins composed of so-called hevein domains [9]. It 
is evident, therefore, that VisalbCBA has nothing in common 
with the previously described V. album lectins MLI, MLI I  and 
MLII I ,  all three of which are genuine type 2 RIP. To the best 
of our knowledge, mistletoe is the first plant species in which 
the simultaneous occurrence of both a typical chitin-binding 
lectin and several type 2 RIP has been demonstrated. In ad- 
dition, besides mistletoe there are only a few other plants in 
which two different ypes of lectins have been found. Several 
legume species are also known to contain two or more lectins. 
However, in all cases the different lectins clearly belong to the 
family of legume lectins [16]. Similarly, the different lectins 
found in elderberry (Sambucus p.) species have all been iden- 
tified as type 2 RIP or proteins derived thereof [17,18]. De- 
tailed studies of the different lectins present in a number of 
monocot species such as garlic (Allium sativum), ramsons (Al- 
lium ursinum) and tulip (Tulipa sp.), have demonstrated that 
they are all closely related at the molecular level [19-21]. 
The discovery of a chitin-binding agglutinin in mistletoe 
raises some intriguing questions about the possible contribu- 
tion of this previously unknown lectin to the presumed bio- 
logical and therapeutic activity of mistletoe preparations. 
Since VisalbCBA is a very stable protein, one can reasonably 
expect hat it survives the processing of the raw materials into 
medicinal preparations much better than the type 2 RIP. 
Therefore, the question must be addressed whether the pres- 
ence of biologically active VisalbCBA contributes to or might 
be responsible for the observed activity of mistletoe prepara- 
tions. It is worth mentioning in this context that the lectin 
from stinging nettle, which closely resembles VisalbCBA with 
respect to its molecular structure and specificity [22], is a 
potent superantigen i mice [10]. On the analogy of the effects 
of the latter lectin, it is quite possible that VisalbCBA influ- 
ences the immune system. Besides a direct effect on the im- 
mune system, VisalbCBA may also indirectly influence the 
immune system through an interaction (either synergistic, ad- 
ditive or antagonistic) with the putative immunomodulatory 
MLI. At present one can only speculate about the possible 
involvement of VisalbCBA in the therapeutic effects of mis- 
tletoe preparations. However, it is of primary importance that 
the presence of this previously unknown chitin-binding lectin 
is considered whenever the biological activities of mistletoe 
preparations or proteins are questioned. 
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